Go long on Sun Pharma

Though the long-term trend remains weak for Sun Pharmaceutical Industries (₹473), in the short term, the stock may show some resilience. It finds immediate resistance at ₹525 and a major one at ₹597.

A close above the latter will even alter the medium-term outlook to positive and lift the stock to ₹621. Sun Pharma, however, finds immediate support at ₹430 and a close below that will reignite the downtrend for the stock.

F&O pointers: The Sun Pharma futures witnessed a rollover of 25 per cent to April series, which is quite healthy. .

Strategy: Expecting a bounce back, we suggest traders to go long on Sun Pharma April futures, which currently quotes at ₹475.50. While a stop-loss can be placed at ₹460, which can be shifted to ₹481 if the stock moves past that level. Traders should keep in mind that the market lot is 1,100 shares and this strategy involves huge margin commitments. Risk-averse traders can stay away from this strategy.

Traders can aim for an initial target of ₹498 or even ₹525, with a trailing stop loss. This position can be held for at least two weeks. Alternatively, they can consider buying ₹480-April call option on Sun Pharma that closed around ₹15. Traders should exit the position, if the premium dips to ₹8 or rises to ₹25.

Follow-up: The stock of Eicher Motors moved on expected lines and hit targets.

Read the rest of this article by Signing up for Portfolio.It's completely free!

What You'll Get

This article is closed for comments.
Please Email the Editor